ALC

#375
Alcon Inc. Ordinary Shares
80.10 USD
+0.41%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
79.98
80.21
Rango anual
71.55
99.20
Cambio diario
+0.41%
Variación mensual
+3.57%
Variación en los últimos 6 meses
+8.07%
Cambio anual
-12.81%
Cierres anteriores
79.77
Abrir
80.11
Bid
Ask
Mínimo
79.98
High
80.21
Volumen
413
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 39.04 B
  • Employee 26 K
  • Founded N/A
  • CEO David J. Endicott
  • Website www.alcon.com
  • Headquarter Switzerland
  • FIGI UNKNOWN
  • Industry Technology
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Alcon Inc

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

Noticias